Last updated on December 2019

A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer


Brief description of study

The purpose of this study is to evaluate the prevalence of 4 or more DNA-repair defects in a population of men with metastatic Prostate Cancer (PC) and to use the variants reported to assess biomarker eligibility for niraparib interventional studies.

Clinical Study Identifier: NCT03871816

Find a site near you

Start Over